FrancophonIA/ELRC3.0 huggingface dataset:
English: Change in PANSS Score 8 week, acute endpoint Mean baseline (SD) Mean change (SD) P-value (vs aripiprazole) Diff. of LS Means (SE)
Croatian: Promjena PANSS rezultata 8 tjedana, akutni ishod Srednja početna vrijednost (SD) Srednja vrijednost promjene (SD)
English: INVEGA doses, which varied across the three studies, ranged from 3 to 15 mg once daily.
Croatian: Doze INVEGE varirale su u ta tri ispitivanja u rasponu od 3 mg do 15 mg jedanput dnevno.
English: - Bottles: The tablets are supplied in a plastic bottle with a child-resistant plastic cap. Each bottle contains either 30 tablets or 350 tablets.
Croatian: - Boce: Tablete se isporučuju u plastičnoj boci s plastičnim sigurnosnim zatvaračem za djecu.
English: Nervous system disorders parkinsonism , akathisia b,
Croatian: Poremećaji živčanog sustava parkinsonizam b,
English: EXP {MM/YYYY}
Croatian: LOCF (engl.
English: Larger decreases in plasma concentrations of paliperidone could occur with higher doses of carbamazepine.
Croatian: Kod primjene većih doza karbamazepina može doći do većih sniženja plazmatske koncentracije paliperidona.
English: Concomitant use of INVEGA with risperidone
Croatian: Istodobna primjena lijeka INVEGA s risperidonom
English: The safety and efficacy of INVEGA in the treatment of schizophrenia in adolescents between 12 and 14 years old has not been established.
Croatian: Sigurnost i djelotvornost lijeka INVEGA u liječenju shizorenije u adolescenata dobi između 12 i 14 godina nisu ustanovljene.
English: Paliperidone is not expected to cause clinically important pharmacokinetic interactions with medicines that are metabolised by cytochrome P-450 isozymes.
Croatian: Mogućnost djelovanja lijeka INVEGE na druge lijekove Ne očekuje se da bi paliperidon izazivao klinički značajne farmakokinetičke interakcije s lijekovima koji se metaboliziraju putem izoenzima citokroma P-450.
English: • development of breasts in men, enlargement of the glands in your breasts, discharge from the breasts, vaginal discharge
Croatian: • razvoj dojki u muškaraca, povećanje žlijezdi u dojkama, iscjedak iz dojki, iscjedak iz rodnice
English: Manufacturer Janssen-Cilag SpA Via C. Janssen 04100 Borgo San Michele Latina
Croatian: Janssen 04100 Borgo San Michele Latina
English: In vitro studies indicate that CYP2D6 and CYP3A4 may be minimally involved in paliperidone metabolism, but there are no indications in vitro nor in vivo that these isozymes play a significant role in the metabolism of paliperidone.
Croatian: Mogućnost djelovanja drugih lijekova na lijek INVEGA In vitro ispitivanja ukazuju na to da CYP2D6 i CYP3A4 mogu biti minimalno uključeni u metabolizam paliperidona, no nema dokaza ni in vitro niti in vivo da ti izoenzimi imaju značajnu ulogu u metabolizmu paliperidona.
English: The recommended starting dose for treating schizophrenia in adolescents 15 years and older is 3 mg once a day taken in the morning.
Croatian: Preporučena početna doza za liječenje shizofrenije u adolescenata dobi 15 godina i starijih je 3 mg jedanput na dan uzeta ujutro.
English: • chest pain, chest discomfort, feeling unwell
Croatian: • bol u prsima, nelagoda u prsima, osjećaj lošeg stanja
English: • blood vessel problems in the brain, coma due to uncontrolled diabetes, unresponsive to stimuli,
Croatian: • problem s krvnim žilama u mozgu, koma radi nekontrolirane šećerne bolesti, neodgovaranje na podražaj, niska razina svijesti, drhtanje glave
English: What INVEGA looks like and contents of the pack INVEGA prolonged-release tablets are capsule shaped.
Croatian: INVEGA tablete s produljenim oslobađanjem imaju oblik kapsule.
English: After having been treated for an acute episode for 6 weeks and stabilised for an additional 8 weeks with INVEGA (doses ranging from 3 to 15 mg once daily) patients were then randomised in a double-blind manner to either continue on INVEGA or on placebo until they experienced a relapse in schizophrenia symptoms.
Croatian: Nakon šestotjednog liječenja akutne epizode i stabilizacije tijekom dodatnih 8 tjedana lijekom INVEGA (doze u rasponu od 3mg do 15 mg jedanput dnevno) bolesnici su u dvostruko slijepom ispitivanju randomizirani ili u skupinu koja je dalje primala lijek INVEGA, ili u skupinu koja je primala placebo sve dok ne bi ponovo nastupio relaps simptoma shizofrenije.
English: 7 & 10 TABLET PVC-PTFE/ALU BLISTER (for white and clear blister)
Croatian: PVC-PTFE/AL BLISTER SA 7 i 10 TABLETA (za bijeli i prozirni blister)
English: EXP MM/YYYY
Croatian: Rok valjanosti MM/GGGG
English: Overall incidence from all clinical trials was 0.14% in all INVEGA-treated subjects Insomnia includes: initial insomnia, middle insomnia; Convulsion includes: grand mal convulsion; Oedema includes: generalised oedema, oedema peripheral, pitting oedema.
Croatian: Insomnija uključuje: inicijalnu insomniju, srednju insomniju; Konvulzije uključuju: grand mal konvulzije; Edem uključuje: generalizirani edem, periferni edem, tjestasti edem.
English: Polyethylene glycol 400 (6, 9 and 12 mg tablet only) Ferric Oxide (Yellow) (E172) (6, 12 mg tablet only) Ferric Oxide (Red) (E172) ( 6, 9 mg tablet only) Lactose monohydrate (3 mg tablet only) Triacetin (3 mg tablet only) Carnauba wax
Croatian: Obojana ovojnica: hipromeloza titanijev dioksid (E171) polietilenglikol 400 (samo tablete od 6, 9 i 12 mg) željezov oksid (žuti) (E172) (samo tablete od 6 i 12 mg) željezov oksid (crveni) (E172) (samo tablete od 6 i 9 mg) laktoza hidrat (samo tablete od 3 mg) triacetin (samo tablete od 3 mg) karnauba vosak
English: Immune system disorders anaphylactic reaction,
Croatian: Poremećaji imunološkog sustava anafilaktička reakcija, preosjetljivost
English: Children and adolescents INVEGA is not for use in children and adolescents under 15 years for the treatment of schizophrenia.
Croatian: INVEGA nije namijenjena za primjenu u djece i adolescenata mlađih od 15 godina za liječenje shizofrenije.
English: waist circumference increased, anorexia, blood triglycerides increased water intoxication, diabetic ketoacidosis c, hypoglycaemia, polydipsia, blood cholesterol increased hyperinsulinaemi
Croatian: hiperglikemija, povećan opseg struka, anoreksija, povišeni trigliceridi u krvi intoksikacija vodom, dijabetička ketoacidoza c, hipoglikemija, polidipsija, povišen kolesterol u krvi hiperinzulinemija
English: • shortness of breath, wheezing, nosebleeds
Croatian: • nedostatak zraka, zviždanje pri disanju, krvarenje iz nosa
English: Abnormalities of electrical function in the heart may occur when this medicine is taken with certain heart medicines that control heart rhythm, or some other types of medicines such as antihistamines, antimalarials, or other antipsychotics.
Croatian: Kada se ovaj lijek uzima s određenim lijekovima za srce, koji kontroliraju srčani ritam ili nekim drugim vrstama lijekova poput antihistaminika, antimalarika ili drugim antipsihoticima, mogu se pojaviti abnormalnosti električne funkcije srca.
English: - if you have diseases associated with diarrhoea.
Croatian: - ako imate bolesti povezane s proljevom - ako imate bubrežne probleme.
English: Oriented polyamide (OPA)-aluminium-polyvinyl chloride (PVC)/aluminium push-through child-resistant blister.
Croatian: Orijentirani poliamid (OPA)-aluminij-polivinilklorid (PVC)/aluminij protisni blister siguran za djecu.
English: • incontinence (lack of control) of urine, frequent passing of urine, inability to pass urine, pain when passing urine
Croatian: • inkontinencija (gubitak kontrole) mokraće, učestalo mokrenje, nemogućnost mokrenja, bol pri mokrenju
English: Schizophrenia: The recommended starting dose of INVEGA for the treatment of schizophrenia in adolescents 15 years and older is 3 mg once daily, administered in the morning.
Croatian: Shizofrenija: Preporučena početna doza lijeka INVEGA za liječenje shizofrenije u adolescenata od 15 godina i starijih je 3 mg jedanput na dan, primjenjeno ujutro.
English: Current or past use of medicines with alpha 1a-adrenergic antagonist effect should be made known to the ophthalmic surgeon in advance of surgery.
Croatian: Prije operativnog zahvata, oftalmolog kirurg mora biti upoznat sa statusom trenutnog ili prethodnog uzimanja lijekova koji imaju učinak alfa 1a adrenergičkih antagonista.
English: The ADRs that appeared to be dose-related included headache, sedation/somnolence, parkinsonism, akathisia, tachycardia, dystonia, dizziness, tremor, upper respiratory tract infection, dyspepsia, and musculoskeletal pain.
Croatian: Nuspojave koje su se činile ovisne o dozi uključivale su glavobolju, sedaciju/somnolenciju, parkinsonizam, akatiziju, tahikardiju, distoniju, omaglicu, tremor, infekciju gornjih dišnih puteva, dispepsiju i mišićno-koštanu bol.
English: Hypromellose Titanium dioxide (E171) Lactose monohydrate Triacetin
Croatian: Ovojnica hipromeloza titanijev dioksid (E171) laktoza hidrat triacetin karnauba vosak
English: Adolescent Schizophrenia Study: R076477-PSZ-3003: 26-week, flexible-dose, active-controlled Intent-to-Treat Analysis Set.
Croatian: Ispitivanje shizofrenije u adolescenata: R076477-PSZ-3003: Analiza podataka bolesnika s namjerom liječenja u 26-o tjednom aktivno kontroliranom ispitivanju s fleksibilnom dozom.
English: INVEGA should not be used while breast feeding.
Croatian: Lijek INVEGA se ne bi trebao primjenjivati tijekom dojenja.
English: BOTTLE CARTON
Croatian: KUTIJA ZA BOCU
English: Paliperidone should not be used in patients with creatinine clearance below 10 mL/min.
Croatian: Ne preporučuje se primjena paliperidona kod bolesnika čiji je klirens kreatinina ispod 10 ml/min.
English: • fever, weakness, fatigue (tiredness).
Croatian: • vrućica, slabost, umor.
English: Swallow whole, do not chew, divide or crush.
Croatian: Tabletu progutajte cijelu, nemojte ju žvakati, lomiti niti usitnjavati.
English: The adverse drug reactions (ADRs) most frequently reported in clinical trials with adults were headache, insomnia, sedation/somnolence, parkinsonism, akathisia, tachycardia, tremor, dystonia, upper respiratory tract infection, anxiety, dizziness, weight increased, nausea, agitation, constipation, vomiting, fatigue, depression, dyspepsia, diarrhoea, dry mouth, toothache, musculoskeletal pain, hypertension, asthenia, back pain, electrocardiogram QT prolonged, and cough.
Croatian: Najčešće nuspojave zabilježene u kliničkim ispitivanjima u odraslih bile su glavobolja, insomnija, sedacija/ somnolencija, parkinsonizam, akatizija, tahikardija, tremor, distonija, infekcija gornjih dišnih puteva, anksioznost, omaglica, povećana težina, mučnina, agitacija, konstipacija, povraćanje, umor, depresija, dispepsija, dijareja, suha usta, zubobolja, mišićno-koštana bol, hipertenzija, astenija, bol u leđima, produljenje QT elektrokardiograma i kašalj.
English: How to store INVEGA
Croatian: Kako čuvati INVEGU
English: Hepatobiliary disorders transaminases increased gamma-glutamyltran sferase increased, hepatic enzyme increased jaundice
Croatian: Poremećaji jetre i žuči povišene transaminaze povišena gamaglutamiltransferaza, povišeni jetreni enzimi žutica
English: • thickening of the skin, dry skin, skin redness, skin discolouration, flaky itchy scalp or skin,
Croatian: • zadebljavanje kože, suha koža, crvenilo kože, promjena boje kože, perutava koža ili vlasište koje svrbi, perut
English: No dose adjustment is required in patients with mild or moderate hepatic impairment.
Croatian: Kod bolesnika s blagim ili umjerenim oštećenjem jetre prilagodbe doze nisu potrebne.
English: Respiratory, thoracic and mediastinal disorders pharyngolarynge al pain, cough, nasal congestion dyspnoea, wheezing, epistaxis sleep apnoea syndrome, hyperventilation, pneumonia aspiration, respiratory tract congestion, dysphonia pulmonary congestion
Croatian: Poremećaji dišnog sustava, prsišta i sredoprsja faringolaringealna bol, kašalj, nazalna kongestija dispneja, piskanje, epistaksa sindrom apneje pri spavanju, hiperventilacija, aspiracijska pneumonija, kongestija dišnih puteva, disfonija pulmonalna kongestija
English: White polyvinyl chloride (PVC) laminated with polychloro-trifluoroethylene (PCTFE)/aluminium push-through layer.
Croatian: Bijeli polivinilklorid (PVC) obložen poliklorotrifluoroetilen (PCTFE)/aluminij protisnim slojem.
English: • sore throat, cough, stuffy nose
Croatian: • grlobolja, kašalj, začepljen nos
English: • symptoms of drug withdrawal.
Croatian: • simptomi ustezanja.
English: Consideration should be given to the prolonged-release nature of the product when assessing treatment needs and recovery.
Croatian: Pri procjeni potrebe liječenja i oporavka treba uzeti u obzir produljeno otpuštanje lijeka.
English: Paliperidone is excreted in the breast milk to such an extent that effects on the breast-fed infant are likely if therapeutic doses are administered to breast-feeding women.
Croatian: Ako dojilja prima terapijske doze, paliperidon se izlučuje u majčino mlijeko u tolikoj mjeri da su učinci na dojenčad vjerojatni.
English: If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse.
Croatian: U slučaju bilo kakvih pitanja u vezi s primjenom ovog lijeka, obratite se liječniku ili ljekarniku.
English: Dosage reduction for INVEGA should be considered when INVEGA is co-administered with valproate after clinical assessment.
Croatian: Nakon kliničke procjene potrebno je razmotriti smanjenje doze lijeka INVEGA kada se primjenjuje istodobno s valproatom.
English: - if you have a swallowing, stomach or intestinal disorder that reduces your ability to swallow or pass foods by normal bowel movements.
Croatian: Vašu sposobnost gutanja ili probavljanja hrane normalnim radom crijeva.
English: Blood and lymphatic system disorders white blood cell count decreased, thrombocytopenia, anaemia, haematocrit decreased agranulocytosis c,
Croatian: Poremećaji krvi i limfnog sustava smanjen broj leukocita, trombocitopenija, anemija, snižen hematokrit agranulocitoza c, neutropenija, povišen broj eozinofila
English: Uncommon side effects: may affect up to 1 in 100 people
Croatian: Manje česte nuspojave: mogu utjecati na do 1 na 100 osoba
English: Musculoskelet al and connective tissue disorders musculoskeletal pain, back pain, arthralgia blood creatine phosphokinase increased, muscle spasms, joint stiffness, joint swelling, muscular weakness, neck pain rhabdomyolysis c, posture abnormal
Croatian: Poremećaji mišićno-koštanog sustava i vezivnog tkiva mišićno-koštana bol, bol u leđima, artralgija povišena kreatinfosfokinaza u krvi, mišićni spazam, ukočenost zglobova, oticanje zglobova, mišićna slabost, bol u vratu rabdomioliza c, nenormalno držanje
English: INVEGA 3 mg prolonged-release tablets INVEGA 6 mg prolonged-release tablets INVEGA 9 mg prolonged-release tablets INVEGA 12 mg prolonged-release tablets
Croatian: INVEGA 3 mg tablete s produljenim oslobađanjem INVEGA 6 mg tablete s produljenim oslobađanjem INVEGA 9 mg tablete s produljenim oslobađanjem INVEGA 12 mg tablete s produljenim oslobađanjem
English: headache dystonia b, dizziness, dyskinesia b,
Croatian: akatizija b, sedacija/ somnolencija glavobolja distonija b, omaglica, diskinezija b,
English: In a long-term trial designed to assess the maintenance of effect, INVEGA was significantly more effective than placebo in maintaining symptom control and delaying relapse of schizophrenia.
Croatian: U dugotrajnom ispitivanju koje je provedeno radi procjene učinka održavanja kontrole simptoma i odgađanju ponovnog nastupa shizofrenije, INVEGA je bila značajno učinkovitija u usporedbi s placebom.
English: INVEGA is for oral administration.
Croatian: INVEGA se primjenjuje peroralno.
English: Common side effects: may affect up to 1 in 10 people
Croatian: Česte nuspojave: mogu utjecati na do 1 na 10 osoba
English: Polyvinyl chloride (PVC) laminated with polychloro-trifluoroethylene (PCTFE)/aluminium push-through layer.
Croatian: Polivinilklorid (PVC) obložen poliklorotrifluoroetilen (PCTFE)/aluminij protisnim slojem.
English: 14 prolonged-release tablets 28 prolonged-release tablets 49 prolonged-release tablets 56 prolonged-release tablets 98 prolonged-release tablets
Croatian: 14 tableta s produljenim oslobađanjem 28 tableta s produljenim oslobađanjem 49 tableta s produljenim oslobađanjem 56 tableta s produljenim oslobađanjem 98 tableta s produljenim oslobađanjem
English: • pneumonia, infection of the breathing passages, bladder infection, ear infection, tonsillitis
Croatian: • upala pluća, infekcija dišnih puteva, infekcija mokraćnog mjehura, infekcija uha, upala krajnika
English: Schizophrenia Studies: Proportion of Subjects with Responder Status at LOCF End Point Studies R076477-SCH-303, R076477-SCH-304, and R076477-SCH-305: Intent-to-Treat Analysis Set
Croatian: Ispitivanja kod shizofrenije: Udio ispitanika koji su imali odgovar na liječenje u LOCF završnoj točki u ispitivanjima R076477-SCH-303, R076477-SCH-304, i R076477-SCH-305: Intent-to-Treat Analysis Set Placebo INVEGA 3 mg
English: When dose increases are indicated, increments of 3 mg/day are recommended and generally should occur at intervals of more than 4 days.
Croatian: U slučaju kada je indicirano povećanje doze, preporučeno je povećavati dozu za 3 mg dnevno i općenito u razdobljima dužim od 4 dana.
English: Schizoaffective Disorder Studies: Secondary Efficacy Parameter, Proportion of Subjects with Responder Status at LOCF End Point: Studies R076477-SCA-3001 and R076477-SCA-3002: Intent-to-Treat Analysis Set
Croatian: Ispitivanja shizoafektivnog poremećaja: Sekundarni parametar djelotvornosti, Udio ispitanika koji su imali odgovor na liječenje u LOCF završnoj točki: ispitivanja R076477-SCA-3001 i R076477-SCA-3002: tzv. Intent-to-Treat Analysis Set
English: The recommended dose of INVEGA for the treatment of schizoaffective disorder in adults is 6 mg once daily, administered in the morning.
Croatian: Preporučena doza lijeka INVEGA za liječenje shizoafektivnog poremećaja u odraslih iznosi 6 mg jedanput dnevno, primjenjeno ujutro.
English: 14 prolonged-release tablets 28 prolonged-release tablets 30 prolonged-release tablets 49 prolonged-release tablets 56 prolonged-release tablets 98 prolonged-release tablets
Croatian: 14 tableta s produljenim oslobađanjem 28 tableta s produljenim oslobađanjem 30 tableta s produljenim oslobađanjem 49 tableta s produljenim oslobađanjem 56 tableta s produljenim oslobađanjem 98 tableta s produljenim oslobađanjem
English: Vascular disorders orthostatic hypotension, hypertension hypotension pulmonary embolism, venous thrombosis,
Croatian: Krvožilni poremećaji ortostatska hipotenzija, hipertenzija hipotenzija plućna embolija, venska tromboza, ishemija, crvenilo uz osjećaj vrućine
English: STATEMENT OF ACTIVE SUBSTANCE(S)
Croatian: Razlika LS srednjih vrijednosti (SE)
English: Adolescent Schizophrenia Study: R076477-PSZ-3001: 6-week, fixed-dose, placebo-controlled Intent-to-Treat Analysis Set.
Croatian: Ispitivanje shizofrenije u adolescenata: R076477-PSZ-3001: Analiza podataka bolesnika s namjerom liječenja (tzv. Intent-to-Treat Analysis Set) u 6-o tjednom placebom kontroliranom ispitivanju s fiksnom dozom.
English: In all three studies, INVEGA was superior to placebo on PSP and CGI-S. Efficacy was also evaluated by calculation of treatment response (defined as decrease in PANSS Total Score ≥ 30%) as a secondary endpoint.
Croatian: Djelotvornost je također bila procjenjena izračunom odgovora na terapiju (definiran kao smanjenje u PANSS ukupnom rezultatu ≥ 30%) kao sekundarna mjera ishoda.
English: Some patients may benefit from higher doses within the recommended range of 6 mg to 12 mg once daily.
Croatian: Neki će bolesnici imati koristi od nižih ili viših doza unutar preporučenog raspona od 6 do 12 mg jedanput dnevno.
English: Iron oxide (Black) (E172) Propylene glycol Hypromellose
Croatian: Tinta za označavanje željezov oksid (crni) (E172) propilenglikol hipromeloza
English: ejaculation disorder, menstrual disorder e, galactorrhoea, sexual dysfunction, breast pain, breast discomfort priapism c, menstruation delayed gynaecomastia, breast engorgement,
Croatian: Poremećaji reproduktivnog sustava i dojki amenoreja erektilna disfunkcija, poremećaj ejakulacije, poremećaj menstruacije c, galaktoreja, seksualna disfunkcija, bol u dojkama, nelagoda u dojkama prijapizam c, odgođena menstruacija c, ginekomastija, nabreklost dojki, povećanje dojki, iscjedak iz dojki, vaginalni iscjedak
English: When dose increases are indicated, increments of 3 mg/day are recommended and generally should occur at intervals of more than 5 days.
Croatian: U slučaju kada je indicirano povećanje doze, preporučeno je dozu povećavati za 3 mg dnevno i općenito u razdobljima dužim od 5 dana.
English: The 3 mg tablet of INVEGA contains lactose
Croatian: Tablete INVEGA od 3 mg sadrže laktozu
English: Manifestation of this increased sensitivity can include confusion, obtundation, postural instability with frequent falls, in addition to extrapyramidal symptoms.
Croatian: Uz pojavu ekstrapiramidnih simptomima, manifestacija povećane osjetljivosti na antipsihotike može uključivati simptome poput smetenosti, tuposti, posturalne nestabilnosti s čestim padovima.
English: An antiemetic effect was observed in preclinical studies with paliperidone.
Croatian: U pretkliničkim ispitivanjima paliperidona opažen je antiemetski učinak.
English: The recommended dose of INVEGA for the treatment of schizophrenia in adults is 6 mg once daily, administered in the morning.
Croatian: Preporučena doza lijeka INVEGA za liječenje shizofrenije u odraslih iznosi 6 mg jedanput dnevno, primijenjena ujutro.
English: Potential for INVEGA to affect other medicines
Croatian: Prijelaz na druge antipsihotičke lijekove
English: confusional state, libido decreased, anorgasmia, nervousness, nightmare catatonia, somnambulism, blunted affect
Croatian: Psihijatrijski poremećaji insomnija manija, agitacija, depresija, anksioznost poremećaj spavanja, stanje konfuzije, smanjen libido, anorgazmija, nervoza, noćne more katatonija, somnambulizam, afektivna tupost
English: electrocardiogram abnormal, palpitations atrial fibrillation, postural orthostatic tachycardia syndrome
Croatian: Srčani poremećaj atrioventrikularni blok, poremećaj provođenja, produljenje QT elektrokardiogram a, bradikardija, tahikardija sinusna aritmija, abnormalan elektrokardiogram, palpitacije atrijska fibrilacija, posturalni ortostatski tahikardijski sindrom
English: Gastrointestin al disorders abdominal pain, abdominal discomfort,
Croatian: Ispitivanja shizoafektivnog poremećaja: Parametar primarne djelotvornosti.
English: Intraoperative Floppy Iris Syndrome
Croatian: Intraoperacijski sindrom meke šarenice (IFIS, engl.
English: pollakiuria, urinary retention, dysuria
Croatian: Poremećaji bubrega i mokraćnog sustava urinarna inkontinencija, polakizurija, urinarna retencija, dizurija
English: Mon, Tue, Wed, Thu, Fri, Sat, Sun
Croatian: Pon, Uto, Sri, Čet, Pet, Sub, Ned
English: The effects of this medicine may be affected if you are taking medicines that affect the speed of movement in the gut (e.g., metoclopramide).
Croatian: Uzimate li lijekove koji utječu na brzinu pokretanja crijeva (npr. metoklopramid), oni mogu imati utjecaj na učinak ovog lijeka.
English: Each INVEGA 9 mg prolonged-release tablet contains 9 mg of paliperidone.
Croatian: Jedna INVEGA tableta s produljenim oslobađanjem od 9 mg sadrži 9 mg paliperidona.
English: Each INVEGA 6 mg prolonged-release tablet contains 6 mg of paliperidone.
Croatian: Jedna INVEGA tableta s produljenim oslobađanjem od 6 mg sadrži 6 mg paliperidona.
English: disturbance in attention, dysarthria, dysgeusia, hypoaesthesia, paresthaesia neuroleptic malignant syndrome, cerebral ischaemia, unresponsive to stimuli c, loss of consciousness, depressed level of consciousness c,
Croatian: tremor tardivna diskinezija, konvulzije e, sinkopa, psihomotorna hiperaktivnost, posturalna omaglica, poremećaj pozornosti, disartrija, disgeuzija, hipoestezija, parestezija maligni neuroleptički sindrom, cerebralna ishemija, neodgovaranje na podražaje c, gubitak svijesti, deprimirana razina svijesti c, dijabetička koma poremećaj ravnoteže, nenormalna koordinacija, titubacija glave
English: Hypromellose Titanium dioxide (E171) Polyethylene glycol 400 Ferric oxide (red) (E172) Carnauba wax
Croatian: Ovojnica hipromeloza titanijev dioksid (E171) polietilenglikol 400 željezov oksid (crveni) (E172) karnauba vosak